Implantierbarer Kardioverter-Defibrillator

详细信息    查看全文

• 作者：Dr. Fritz W. Horlbeck M.D. ; J.O. Schwab M.D.
• 关键词：Implantierbarer Kardioverter ; Defibrillator ; Kardiale Resynchronisation ; Herzinsuffizienz ; Mortalit?t ; Kosten ; Nutzen ; Analyse ; Implantable cardioverter ; defibrillator ; Cardiac resynchronization therapy ; Heart failure ; Mortality ; Cost ; benefit analysis
• 刊名：Herzschrittmachertherapie und Elektrophysiologie
• 出版年：2015
• 出版时间：June 2015
• 年：2015
• 卷：26
• 期：2
• 页码：116-122
• 全文大小：538 KB
• 参考文献：1.Boriani G, Da Costa A, Ricci RP et al (2013) The MOnitoring Resynchronization dEvices and CARdiac patiEnts (MORE-CARE) randomized controlled trial: phase 1 results on dynamics of early intervention with remote monitoring. J Med Internet Res 15:e167PubMed Central PubMed View Article
  2.Brachmann J, Bohm M, Rybak K et al (2011) Fluid status monitoring with a wireless network to reduce cardiovascular-related hospitalizations and mortality in heart failure: rationale and design of the OptiLink HF Study (Optimization of Heart Failure Management using OptiVol Fluid Status Monitoring and CareLink). Eur J Heart Fail 13:796-04PubMed Central PubMed View Article
  3.Conraads VM, Tavazzi L, Santini M et al (2011) Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial. Eur Heart J 32:2266-273PubMed View Article
  4.Crossley GH, Boyle A, Vitense H et al (2011) The CONNECT (Clinical evaluation of remote notification to reduce time to clinical decision) trial: the value of wireless remote monitoring with automatic clinician alerts. J Am Coll Cardiol 57:1181-189PubMed View Article
  5.Dubner S, Auricchio A, Steinberg JS et al (2012) ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs). Ann Noninvasive Electrocardiol 17:36-6PubMed View Article
  6.European Heart Rhythm Association, European Society of Cardiology, Heart Rhythm Society et al (2012) 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Heart Rhythm 9:1524-576View Article
  7.European Society of Cardiology, European Heart Rhythm Association; Brignole M et al (2013) 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace 15:1070-118View Article
  8.Guedon-Moreau L, Kouakam C, Klug D et al (2014) Decreased delivery of inappropriate shocks achieved by remote monitoring of ICD: a substudy of the ECOST trial. J Cardiovasc Electrophysiol 25:763-70PubMed View Article
  9.Guedon-Moreau L, Lacroix D, Sadoul N et al (2013) A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial. Eur Heart J 34:605-14PubMed Central PubMed View Article
  10.Heidbuchel H, Hindricks G, Broadhurst P et al (2015) EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoring. Eur Heart J 36:158-69PubMed Central PubMed View Article
  11.Hernandez-Madrid A, Lewalter T, Proclemer A et al (2014) Remote monitoring of cardiac implantable electronic devices in Europe: results of the European heart rhythm association survey. Europace 16:129-32PubMed View Article
  12.Hindricks G, Elsner C, Piorkowski C et al (2014) Quarterly vs. yearly clinical follow-up of remotely monitored recipients of prophylactic implantable cardioverter-defibrillators: results of the REFORM trial. Eur Heart J 35:98-05PubMed Central PubMed View Article
  13.Hindricks G, Taborsky M, Glikson M et al (2014) Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Lancet 384:583-90PubMed View Article
  14.Ip J, Waldo AL, Lip GY et al (2009) Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study. Am Heart J 158:364-70e361PubMed View Article
  15.Koneru JN, Gunderson BD, Sachanandani H et al (2013) Diagnosis of high-voltage conductor fractures in Sprint Fidelis leads. Heart Rhythm 10:813-18PubMed View Article
  16.Landolina M, Perego GB, Lunati M et al (2012) Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study. Circulation 125:2985-992PubMed View Article
  17.Mabo P (2011) Evaluation of the ?Tele-follow-up-for the Follow-up of Implantable Defibrillators (EVATEL). https://?www.?clinicaltrials.?gov/?ct2/?show/?NCT00598026??term=?EVATEL&?rank=- . http://?cardioletter.?de/?fileupload/?Mabo.?pdf . http://?www.?escardio.?org/?The-ESC/?Press-Office/?Press-releases/?Last-5-years/?Potential-benefits-of-remotefollow-up-of-ICD-patients-the-EVATEL-trial
  18.Mairesse GH, Braunschweig F, Klersy K et al (2015) Implementation and reimbursement of remote monitoring for cardiac impl
• 作者单位：Dr. Fritz W. Horlbeck M.D. (1)
  J.O. Schwab M.D. (2)
  
  1. Medizinische Klinik II, Kardiologie, Angiologie, Pneumologie und Intensivmedizin -Universit?tsklinikum Bonn, Bonn, Deutschland
  2. Privatpraxis für spezielle Rhythmologie, Konservative und Interventionelle Kardiologie, Beta Klinik, Bonn, Deutschland
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Cardiology
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1435-1544

文摘

Background The possibilities of telemonitoring (TM) of patients with implantable cardioverter–defibrillators (ICD) have been rapidly improving over the last few years. Numerous studies have examined the effects of this development on the follow-up care of ICD patients. Objectives Technical implementation and safety of ICD telemonitoring. Effects on the treatment of cardiac arrhythmias, the management of cardiac insufficiency patients and morbidity as well as mortality. Illustration of patient acceptance and cost–benefit assessment. Materials and methods The current research situation regarding TM of ICDs is analyzed and the available evidence for the postulated advantages in the follow-up care of ICD patients are discussed. The current treatment guidelines and recommendations for implementation of TM in daily clinical praxis are presented. Results and Conclusions TM offers the possibility of faster reaction times to arrhythmias, cardiac decompensation and ICD malfunctions. At the same time, the outpatient follow-ups can be reduced without negatively affecting safety, quality of life or patient acceptance. TM has the potential to cost-neutrally improve the safety of ICD therapy and could lead to optimized management of heart insufficiency patients, while reducing morbidity and mortality. Following the evidence of these benefits as shown in numerous studies, TM has already been included in the current therapy guidelines.